Blue Clay Capital Management’s Evolent Health EVH Stock Holding History

Blue Clay Capital Management’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-23,740	Closed	-$456K	–	112
2016 Q2	$456K	Sell	23,740 -9,900	-29%	-$136K	0.53%	48
2016 Q1	$355K	Hold	33,640	–	–	0.33%	75
2015 Q4	$407K	Buy	33,640 +2,240	+7%	+$33K	0.34%	72
2015 Q3	$501K	Hold	31,400	–	–	0.4%	60
2015 Q2	$612K	Buy	+31,400	New	+$585K	0.35%	57

Other funds holding EVH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PCM

Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

Blue Clay Capital Management's EVH Position: Q3 2016 in Review

Blue Clay Capital Management sold out of Evolent Health (EVH) in Q3 2016, closing a stake of 23,740 shares — an estimated $456K sold.

Blue Clay Capital Management first reported a position in EVH in Q2 2015 and held it in 5 quarters. The position peaked at $612K in Q2 2015. 110 funds tracked by Wall St. Rank hold EVH as of Q3 2016.

Blue Clay Capital Management reported no remaining Evolent Health position as of Q3 2016 after selling out during the quarter.
Blue Clay Capital Management sold 23,740 Evolent Health shares in Q3 2016, an estimated $456K.
Blue Clay Capital Management first reported a position in Evolent Health in Q2 2015 and held it in 5 quarters.
Blue Clay Capital Management's Evolent Health position peaked at $612K in Q2 2015.
110 funds tracked by Wall St. Rank held Evolent Health as of Q3 2016.

Based on Blue Clay Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.